Hedge Funds Have Never Been This Bullish On Retrophin Inc (RTRX)
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Posts Tagged ‘NASDAQ:RTRX’
Did Hedge Funds Make The Right Call On Retrophin Inc (RTRX) ?
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file ...
Retrophin Inc (RTRX): Hedge Funds Sticking Around
In this article you are going to find out whether hedge funds think Retrophin Inc (NASDAQ:RTRX) is a good investment right now.
These Hedge Funds Cashed Out Of Retrophin Inc (RTRX) Too Early
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Is Retrophin Inc (RTRX) Going To Burn These Hedge Funds ?
The 700+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the second quarter, which unveil their equity...
Here’s What Hedge Funds Think About Retrophin Inc (RTRX)
Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics ...
Retrophin Inc (RTRX) Hedge Funds Are Snapping Up
Is Retrophin Inc (NASDAQ:RTRX) a good stock to buy right now? We at Insider Monkey like to examine what billionaires and hedge funds think of a company before doing days of research...
Is Retrophin Inc (RTRX) A Good Stock To Buy?
Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable...
Horizon Pharma PLC (HZNP), Flamel Technologies S.A. (ADR) (FLML) & More: Why Should You Consider Following Broadfin Capital’s Investment Moves?
At Insider Monkey, we think that an investor can beat the market by imitating smart moves of big hedge funds into the top pick they are bullish on.
Biotech Movers: Retrophin Inc (RTRX) and Agios Pharmaceuticals Inc (AGIO)
Summer is officially over, and the warm weather volume lull is has come to an end.
What Will Retrophin Inc (RTRX) Get For Its Money On A Raptor Pharmaceutical Corp. (RPTP) Deal?
The rumor mill is working hard right now in the biotech space, and the latest word is that Retrophin Inc (NASDAQ:RTRX), the company founded by Martin Shkreli, is pitching to buy...
Retrophin Inc. (RTRX): Scopia Capital Adds To Its Stake
Matt Sirovich and Jeremy Mindich's Scopia Capital has recently filed an amended 13G with the SEC, in which reported holding 3.84 million common shares of Retrophin Inc.
Retrophin, Inc. (RTRX): Hedge Funds Are Crazy About This Fallen Angel
Retrophin, Inc. (NASDAQ:RTRX) shares were trading as high as $37 last summer but like most small-cap biotech stocks lost a large chunk of its value since then.
Kevin Kotler’s Healthcare Fund Broadfin Capital Just Had A Disastrous Q1
Though 2016 hasn't been great for the overall hedge fund industry so far, it is turning out to be an especially terrible year for biotech-focused hedge funds.
Top Biotech Picks of Best-Performing Hedge Fund of 2015
Bloomberg recently came out with its list of best performing hedge funds of 2015 and the fund that managed to beat all its rivals and emerge at the top of the list was biotech...
Retrophin Inc (RTRX): Are Hedge Funds Right About This Stock?
Is Retrophin Inc (NASDAQ:RTRX) a good stock to buy right now? We at Insider Monkey like to examine what billionaires and hedge funds think of a company before doing days of research...
Healthcare Fund Consonance Capital’s Top Picks For Q3 Following Monster First Half
The healthcare sector has appreciated by more than 14% so far this year, so we decided to take a look at how healthcare funds are gearing their portfolios heading into the second...
Broadfin Capital Discloses New Stake in This Canadian Biotechnology Company
Broadfin Capital, led by Kevin Kotler, has initiated a new position in QLT Inc. (USA) (NASDAQ:QLTI). In a new filing with the U.S.
Amicus Therapeutics, Inc. (FOLD), Neurocrine Biosciences, Inc. (NBIX), and Retrophin Inc (RTRX) among Biotech Guru Joseph Edelman’s Top Healthcare Picks
Biotech Guru Joseph Edelman's Perceptive Advisors is known for its long-short investment approach that focuses on biotech stocks.
More Than 60% Returns For These Two Hedgies’ Favorite Health Care Picks
The health care sector has appreciated by nearly 30% over the past year. We decided to take a look at three companies that two health care-focused funds, namely James A.
Recent Changes in SAC Capital Advisors’ Equity Portfolio
Steven Cohen's SAC Capital Advisors cut its exposure to a certain number of positions.
Steven Cohen Also Initiates Stake in Retrophin Inc (RTRX)
Steven Cohen, in a new filing with the SEC disclosed initiating a stake in Retrophin Inc (NASDAQ:RTRX). According to the filing, Mr.
Broadfin Capital Initiates a Stake in Retrophin Inc (RTRX) Following Its Listing on NASDAQ
Kevin Kotler’s Broadfin Capital has revealed a new stake in Retrophin Inc (NASDAQ:RTRX), which amasses 6.93% of the company’s common stock, it contains 1.61 million shares...
